Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

15.91
Delayed Data
As of Dec 02
 -0.19 / -1.18%
Today’s Change
5.25
Today|||52-Week Range
18.24
+29.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization159.0K46.0K96.0K--
 
 
 
 
 
Operating ExpensesGross Income-159.0K-46.0K-96.0K0.00
 
 
 
 
General Expenses10.2M6.4M3.4M14.1M
 
 
 
 
 
Research And Development7.2M3.4M-103.0K7.8M
 
 
 
 
 
Total Operating Expenses10.4M6.4M3.5M14.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.4M-6.4M-3.5M-14.1M
 
 
 
 
 
Interest Expense On Debt156.0K77.0K0.00--
 
 
 
Other Expenses0.000.0091.0K--
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.5M-6.5M-3.4M-14.0M
 
 
 
 
 
Net Income-10.5M-6.5M-3.4M-14.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.9M3.9M3.9M10.5M
 
 
 
 
 
Shares To Calculate EPS Diluted3.9M3.9M3.9M10.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.80-$1.75-$0.70-$1.34
 
 
 
 
 
EPS Diluted-$2.80-$1.75-$0.70-$1.34